|
Research Management and Support
|
RMS ES 2018
|
$340,640,887
|
$108,000
|
N/A
|
National Institutes of Health
|
|
Sphingolipid Signaling in Mammals
|
ZIA BC 011187
|
$679,649
|
$679,649
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Nanoparticle mediated microenvironmental targeting of CCL3 signaling for the treatment of acute myelogenous leukemia
|
1F31CA228391-01
|
$42,418
|
$13,998
|
ACKUN-FARMMER, MARIAN
|
UNIVERSITY OF ROCHESTER
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-05S1
|
$2,256,906
|
$756,064
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-05
|
$20,853,800
|
$6,986,023
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.
|
5R01CA133379-10
|
$381,375
|
$190,688
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Long non-coding RNAs in hematopoiesis and blood malignancy
|
5R01CA194923-04
|
$457,533
|
$228,767
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Mapping cancer micro-environments for acute leukemia
|
5R01CA202025-03
|
$455,870
|
$227,935
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 07130
|
$1,652,758
|
$1,652,758
|
Alter, Blanche
|
DCEG (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$753,084
|
$37,654
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Collaborative Pathways that Lead to Leukemia
|
ZIA BC 010982
|
$437,122
|
$437,122
|
Aplan, Peter
|
CCR (NCI)
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$374,676
|
$187,338
|
Aplan, Peter
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
ZIA SC 010379
|
$62,446
|
$12,489
|
Aplan, Peter
|
CCR (NCI)
|
|
COMPRENDO: Adaptation and Implementation of a Peer-Navigation Intervention to Improve Research Literacy and Diversity in Pediatric Leukemia Clinical Trials
|
1K08CA230306-01
|
$254,821
|
$254,821
|
ARISTIZABAL, PAULA
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Targeting DOT1L for Degradation in MLL-rearranged Leukemia
|
2R01CA176745-07
|
$404,076
|
$404,076
|
ARMSTRONG, SCOTT
|
DANA-FARBER CANCER INST
|
|
Childhood Cancer Survivor Study
|
3U24CA055727-24S1
|
$120,439
|
$24,088
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Research Training in Pediatric Oncology
|
5T32CA136432-10
|
$491,462
|
$491,462
|
ARMSTRONG, SCOTT
|
DANA-FARBER CANCER INST
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-24
|
$4,218,764
|
$843,753
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
$477,263
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S1
|
$84,000
|
$5,040
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S2
|
$206,488
|
$12,389
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S3
|
$257,838
|
$15,470
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Targeting the TGIF/Twist1 network in osteosarcoma
|
5R01CA210911-02
|
$348,844
|
$348,844
|
ATFI, AZEDDINE
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
5R01CA138744-09
|
$343,388
|
$343,388
|
BAKER, SHARYN
|
OHIO STATE UNIVERSITY
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$153,792
|
Barr, Frederic
|
CCR (NCI)
|
|
Regulation of Ceramide-Based Therapeutics in Acute Myeloid Leukemia
|
5K22CA190674-04
|
$161,692
|
$40,423
|
BARTH, BRIAN
|
UNIVERSITY OF NEW HAMPSHIRE
|
|
Early Life Exposures in Agriculture
|
ZIA CP010119 10737
|
$793,079
|
$396,539
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-18
|
$672,442
|
$336,221
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pediatric Oncology Research Training Program
|
5T32CA009351-40
|
$250,143
|
$125,072
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The role of H3K79 methylation in IDH-mutant leukemia
|
5R01CA201230-04
|
$438,616
|
$438,616
|
BERNT, KATHRIN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Pediatric CT Scans
|
ZIA CP010222 04122
|
$37,589
|
$37,589
|
Berrington, Amy
|
DCEG (NCI)
|
|
Histone deacetylases 1,2 and DNA repair
|
3R01CA188520-04S1
|
$20,472
|
$10,236
|
BHASKARA, SRIVIDYA
|
UNIVERSITY OF UTAH
|
|
Genome maintenance by Hdacs1,2 and their inhibition for Pre-B leukemia therapy
|
5R01CA188520-04
|
$340,838
|
$170,419
|
BHASKARA, SRIVIDYA
|
UNIVERSITY OF UTAH
|
|
Comprehensive Approach to Improve Medicine Adherence in Pediatric Leukmia
|
5R01CA174683-05
|
$597,219
|
$597,219
|
BHATIA, SMITA
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
3P30CA013148-46S1
|
$52,084
|
$2,083
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
3P30CA013148-46S2
|
$72,961
|
$2,918
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
3P30CA013148-46S3
|
$91,218
|
$3,649
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
3P30CA013148-46S4
|
$45,500
|
$1,820
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
3P30CA013148-46S5
|
$198,945
|
$7,958
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
5P30CA013148-46
|
$5,104,077
|
$204,163
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
The Role of Protein Tyrosine Phosphate PRL3 in Leukemia Development
|
5R00CA181500-05
|
$248,999
|
$248,999
|
BLACKBURN, JESSICA
|
UNIVERSITY OF KENTUCKY
|
|
The role of the histone chaperone Chaf1b in sustaining the Hoxa9-driven AML differentiation block
|
1K22CA214849-01
|
$191,970
|
$191,970
|
BLANCO, MARIO
|
UNIVERSITY OF PENNSYLVANIA
|
|
Material Hardship as a Targetable Measure of Poverty in Pediatric Cancer
|
5K07CA211847-03
|
$133,475
|
$133,475
|
BONA, KIRA
|
DANA-FARBER CANCER INST
|
|
Dissection of eIF4E dependent mRNA export
|
5R01CA080728-18
|
$210,799
|
$52,700
|
BORDEN, KATHERINE
|
UNIVERSITY OF MONTREAL
|
|
Molecular Mechanisms of eIF4E mediated transformation
|
5R01CA098571-14
|
$227,057
|
$113,529
|
BORDEN, KATHERINE
|
UNIVERSITY OF MONTREAL
|
|
Integrative Molecular Epidemiology of Neurocognitive Outcomes in Acute Lymphoblastic Leukemia
|
1K07CA218362-01A1
|
$166,043
|
$166,043
|
BROWN, AUSTIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Chronic graft-versus-host disease in children and young adults
|
ZID BC 011729
|
$10,952
|
$3,285
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA016058-42S1
|
$59,783
|
$598
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Commercializing Praedicare Dx TM platform for guiding cancer treatments
|
5R44CA203610-03
|
$991,179
|
$99,118
|
CARDONE, MICHAEL
|
EUTROPICS PHARMACEUTICALS, INC.
|
|
Targeting NEDD8-Mediated Protein Turnover in AML
|
5R01CA172443-05
|
$286,661
|
$71,665
|
CAREW, JENNIFER
|
UNIVERSITY OF ARIZONA
|
Total relevant funding to Childhood Leukemia for this search: $87,288,663
|